ERGO — Entia Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.97m
- $0.27m
Annual cashflow statement for Entia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.26 | -3.1 | -2.3 | -2.26 | -1.4 |
| Depreciation | |||||
| Non-Cash Items | 0.618 | 1.69 | 1 | 0.862 | 0.181 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.31 | 0.613 | 0.579 | 0.829 | 0.482 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.315 | -0.767 | -0.68 | -0.537 | -0.715 |
| Capital Expenditures | -0.017 | -0.053 | -0.005 | -0.008 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.046 | -0.012 | -0.041 | -0.013 | -0.007 |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.063 | -0.065 | -0.045 | -0.021 | -0.007 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.374 | 0.855 | 0.788 | 0.483 | 0.774 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.004 | 0.024 | 0.063 | -0.075 | 0.052 |